Kyntra Bio
KYNB
134 hedge funds and large institutions have $963M invested in Kyntra Bio in 2015 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 49 increasing their positions, 32 reducing their positions, and 15 closing their positions.
113% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 15
53% more repeat investments, than reductions
Existing positions increased: 49 | Existing positions reduced: 32
53% more capital invested
Capital invested by funds: $629M → $963M (+$334M)
14% more funds holding
Funds holding: 118 → 134 (+16)
8% more call options, than puts
Call options by funds: $3.09M | Put options by funds: $2.86M
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$20.1M |
| 2 |
State Street
Boston,
Massachusetts
|
+$11M |
| 3 |
HCMT
Highland Capital Management (Texas)
Dallas,
Texas
|
+$11M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$10.1M |
| 5 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$6.22M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
-$7.53M |
| 2 |
Franklin Resources
San Mateo,
California
|
-$7.29M |
| 3 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$5.13M |
| 4 |
HCM
Highbridge Capital Management
New York
|
-$3.51M |
| 5 |
Millennium Management
New York
|
-$3.28M |
KYNB Hedge Fund Activity: Q4 2015 in Review
134 of the 3,823 institutional investors tracked by Wall St. Rank reported a position in Kyntra Bio (KYNB) for Q4 2015, worth a combined $963M — up 53% from $629M a quarter earlier.
Buyers outnumbered sellers: 32 funds opened new KYNB positions and 15 closed out — a net gain of 17 holders — while 49 added to existing stakes and 32 trimmed.
The largest buyer was BlackRock Fund Advisors, adding an estimated $20.1M. The largest seller was Adage Capital Partners, cutting an estimated $7.53M.
- 134 institutional investors held Kyntra Bio (KYNB) as of Q4 2015, up from 118 in Q3 2015.
- Funds reported $963M of Kyntra Bio stock for Q4 2015, up 53% quarter-over-quarter.
- 32 funds opened new Kyntra Bio positions in Q4 2015 and 15 closed out, a net change of +17 holders.
- The largest Kyntra Bio buyer in Q4 2015 was BlackRock Fund Advisors, an estimated $20.1M added.
- The largest Kyntra Bio seller in Q4 2015 was Adage Capital Partners, an estimated $7.53M sold.
Based on aggregated 13F filings for Q4 2015.